|« Previous month||Next month »|
30-Sep-2015 - Drug companies still outsource to cut costs but environmental concerns and therefore contractors’ green credentials are increasingly important say industry experts.
30-Sep-2015 - The FDA will begin destroying drugs which are refused entry to the US instead of returning them to their sender.
30-Sep-2015 - Teva has acquired Gecko Health Innovations, adding an inhaler app it says can help patients manage asthma and COPD.
29-Sep-2015 - A UK supplier of metal catalysts to the drug industry has been fined after an explosion at its site in Widnes left an employee with minor injuries.
29-Sep-2015 - Blocking the neuropeptides that regulate arousal and appetite could lead to a treatment for cocaine addiction, says Heptares which has received an NIH development grant.
29-Sep-2015 - Novartis has extended a deal with Unilife for the supply of an injectable drug delivery system for use with an early stage drug candidate.
29-Sep-2015 - Polpharma has continued its biosimilar-focused hiring spree and appointed Maurice Chagnaud as its CEO.
28-Sep-2015 - The US FDA has revoked approval for Sun Pharmaceutical Industries’ extended-release epilepsy drug Elepsia XR over concerns the firm's manufacturing plant in Halol, India does not meet quality standards.
28-Sep-2015 - Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.
28-Sep-2015 - GSK is selling a French R&D site as part of a global restructuring move but says it will continue growing its manufacturing presence in the country.
25-Sep-2015 - Air pollution increases the likelihood that people genetically predisposed to Alzheimer’s will develop the disease according to Mexican researchers.
24-Sep-2015 - Better health monitoring could cut the number of adverse drug reactions and guide development of safer formulations say researchers.
24-Sep-2015 - It will be business as usual for pharma customers as Ashland approves a plan to separate into two independent companies, the ingredients firm says.
23-Sep-2015 - India may classify vitamin supplements as drugs rather than foods if the manufacturers of such products claim they can treat or prevent disease.
23-Sep-2015 - Electricity from a ‘green energy’ biomass plant being built nearby will cut utility costs at an Aesica UK facility and help the CDMO stay competitive.
23-Sep-2015 - European regulators and the WHO have begun sharing confidential information about drug applications, quality, and inspections under a new agreement.
23-Sep-2015 - Drugmakers need more certainty and reliabilty around their supply chain in light of increased regulatory vigilance says Mylan, itself carrying out remediation across several Indian facilities.
23-Sep-2015 - Pfizer has agreed to sell a manufacturing facility in India to Vidhi Research and Development for around $27m.
22-Sep-2015 - UK scientists have applied to the country’s fertility regulator for permission to use CRISPR and other genome editing techniques on human embryos.
22-Sep-2015 - Novo Nordisk will build a manufacturing plant for its FlexPen prefilled insulin device in Iran to cater for the local market.
22-Sep-2015 - Amgen could pay up to $1.25bn Dezima Pharma if its promising lead candidate - the cholesterol buster TA-8995 - is approved.
22-Sep-2015 - Cilian has teamed up with Glide Technologies to develop a solid dose influenza vaccine to be delivered via a needle-free injector.
22-Sep-2015 - The UK government is granting £1.9m ($2.9m) to pharma company Mission Therapeutics to create small-molecule cancer inhibitors.
22-Sep-2015 - Sandoz has reiterated its call for US FDA guidance on biosimilar interchangeability arguing that the lack of clarity makes it hard to gauge what impact switching rules will have on...
|« Previous month||Next month »|